Stockreport

Sensei Biotherapeutics to Present at Upcoming Conferences

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and developmen [Read more]